Summary:
CTT is conducting a clinical research study investigating an innovative approach to delivering treatment for type 2 diabetes that doesn't require needles or even pills.
Qualified Participants Must:
Be between 18 and 80 years of age
Have been diagnosed with Type 2 Diabetes for more than 3 months
Be taking Metformin on a daily basis
Qualified Participants May Receive:
Investigational product, examinations and medical care at no cost. Compensation for time and travel may be available.